Raphael Mechoulam Selected Research

cannabidiol-dimethylheptyl

10/2003

Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphael Mechoulam Research Topics

Disease

18	Nausea 02/2022 - 04/2002
15	Inflammation (Inflammations) 09/2021 - 12/2004
13	Neoplasms (Cancer) 01/2022 - 03/2003
12	Vomiting 02/2022 - 03/2003
7	Schizophrenia (Dementia Praecox) 01/2022 - 01/2007
7	Pain (Aches) 01/2022 - 12/2004
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2005
7	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 10/2009
6	Infarction (Infarctions) 01/2019 - 08/2003
6	Multiple Sclerosis 01/2016 - 04/2006
5	Closed Head Injuries 01/2019 - 04/2005
5	Parkinson Disease (Parkinson's Disease) 08/2011 - 08/2003
4	Cognitive Dysfunction 01/2022 - 08/2007
4	Obesity 09/2021 - 01/2007
4	Epilepsy (Aura) 01/2020 - 01/2007
4	Osteoporosis 10/2019 - 01/2007
4	Neuroinflammatory Diseases 01/2019 - 05/2008
4	Huntington Disease (Huntington's Disease) 02/2013 - 01/2007
4	Hepatic Encephalopathy 09/2009 - 01/2006
3	Infections 01/2021 - 12/2018
3	Fibrosis (Cirrhosis) 09/2016 - 09/2009
3	Reperfusion Injury 01/2016 - 05/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 05/2008
3	Liver Diseases (Liver Disease) 09/2009 - 01/2006
2	COVID-19 10/2022 - 01/2021
2	Hypothermia 01/2022 - 10/2017
2	Catalepsy 01/2022 - 10/2017
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2020
2	Tobacco Use Disorder (Nicotine Dependence) 09/2020 - 01/2019
2	Anhedonia 09/2020 - 01/2016
2	Body Weight (Weight, Body) 02/2020 - 03/2005
2	Sleepiness 01/2019 - 05/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 12/2007
2	Ischemia 01/2016 - 05/2011
2	Experimental Arthritis 10/2015 - 03/2004
2	Cardiotoxicity 01/2015 - 08/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2011 - 01/2008

Drug/Important Bio-Agent (IBA)

42	CannabinoidsIBA 01/2022 - 02/2002
34	CannabidiolIBA 10/2022 - 04/2002
23	EndocannabinoidsIBA 05/2022 - 02/2002
9	Dronabinol (THC)FDA LinkGeneric 07/2017 - 01/2004
7	AntiemeticsIBA 02/2022 - 07/2004
6	Lithium ChlorideIBA 02/2022 - 04/2002
6	cannabidiolic acidIBA 01/2021 - 07/2017
6	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
6	Glycerol (Glycerine)FDA LinkGeneric 05/2016 - 02/2002
5	AmidesIBA 02/2022 - 10/2018
5	CB2 Cannabinoid ReceptorIBA 01/2022 - 08/2009
5	Pharmaceutical PreparationsIBA 09/2021 - 12/2007
5	EstersIBA 01/2021 - 01/2018
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2008
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 01/2004
5	Cannabinoid Receptor AgonistsIBA 01/2016 - 02/2002
5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 02/2007
5	Neuroprotective AgentsIBA 08/2011 - 02/2002
5	LithiumIBA 02/2008 - 03/2003
4	Morphine (MS Contin)FDA LinkGeneric 02/2022 - 02/2020
4	Naloxone (Narcan)FDA LinkGeneric 02/2022 - 02/2020
4	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 01/2019
4	muskIBA 02/2022 - 01/2004
4	quinone (benzoquinone)IBA 03/2021 - 07/2004
4	cannabidiol hydroxyquinone (HU331)IBA 03/2021 - 07/2006
4	Serine (L-Serine)FDA Link 10/2019 - 06/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 02/2002
3	Therapeutic UsesIBA 10/2022 - 09/2009
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 02/2013
3	Medical MarijuanaIBA 01/2022 - 01/2018
3	HU-910IBA 01/2022 - 04/2012
3	N-oleoylglycineIBA 01/2021 - 01/2020
3	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021 - 02/2013
3	5-HT1A Serotonin ReceptorIBA 09/2020 - 06/2011
3	anandamide (arachidonylethanolamide)IBA 09/2020 - 02/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2006
3	AM 251 (AM251)IBA 01/2019 - 04/2012
3	3-nitrotyrosineIBA 01/2017 - 05/2011
3	HU 308IBA 09/2016 - 12/2008
3	CytokinesIBA 10/2015 - 05/2006
3	AntioxidantsIBA 02/2013 - 01/2004
3	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 05/2011 - 04/2005
3	EmeticsIBA 01/2006 - 04/2002
2	Alanine (L-Alanine)FDA Link 02/2022 - 09/2020
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2022 - 09/2020
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022 - 01/2019
2	Calcium Gluconate (CBG)IBA 09/2021 - 06/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2020
2	HU-580IBA 09/2020 - 01/2018
2	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 08/2003
2	SaccharinIBA 09/2020 - 06/2011
2	Methylazoxymethanol AcetateIBA 01/2020 - 01/2019
2	LipidsIBA 10/2018 - 08/2011
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2018 - 06/2011
2	Transaminases (Aminotransferases)IBA 01/2017 - 05/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 08/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2015 - 05/2011
2	N-arachidonoyl L-serineIBA 08/2013 - 08/2011
2	Arachidonic Acid (Vitamin F)IBA 04/2012 - 12/2004

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2006
6	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
3	Ovariectomy (Oophorectomy) 10/2019 - 10/2010